U.S. Real Estate Stock News

Why ONEOK’s Permian build out is back in focus ONEOK (OKE) is back on many investors’ radar after securing a fuller presence in the Permian Basin through deals and expansion projects, with integration moving faster than management initially expected. See our latest analysis for ONEOK. ONEOK’s share price has been relatively steady, with a 90 day share price return of 4.48% around the current US$72.70 level. The 1 year total shareholder return of 26.40% decline contrasts with a 120.27% gain...

Nova (NVMI) is back in focus after reporting record third quarter results. Revenue was up 25.5% year on year, and demand in leading semiconductor nodes and advanced packaging helped it outperform analyst expectations. See our latest analysis for Nova. Novo’s recent record quarter has coincided with a 24.8% 30 day share price return and a 25.5% 90 day share price return, while its 1 year total shareholder return of 80.9% and very large 5 year total shareholder return indicate that strong...

F5, Inc. previously disclosed a material cybersecurity incident involving unauthorized access to its BIG-IP product development environment, including exfiltration of sensitive source code, which was later linked to reduced fiscal 2026 revenue guidance and has since prompted multiple securities class action lawsuits alleging misleading disclosures about the breach. The wave of law firm announcements and class action filings raises broader questions about F5’s security credibility, disclosure...

In early January 2026, MUSC Health announced a multi-year partnership with Baxter International to improve patient care using integrated connected care technologies, aiming to streamline bedside workflows, enhance quality and safety, and boost nurse satisfaction through advanced data and automation tools. This collaboration positions Baxter as a key partner in shaping future nursing workflows and connected hospital infrastructure, potentially making its digital and automation capabilities...

With no single headline event driving attention, Concentrix (CNXC) is drawing interest as investors weigh its recent share performance, current valuation metrics, and the scale of its customer experience business. See our latest analysis for Concentrix. Recent trading has been mixed, with a 7 day share price return of 3.33% and a 30 day share price return of 11.35%, set against a 1 year total shareholder return decline of 3.29% and a 3 year total shareholder return decline of 67.82%. This...

Recent analyst upgrades and more supportive recommendations have pushed Truist Financial (TFC) into the spotlight, as firms reassess the bank’s dividend appeal, digital banking investments, and role in a stabilizing sector. See our latest analysis for Truist Financial. Those analyst upgrades come after a solid run in the share price, with a 90 day share price return of 15.23% and a 1 year total shareholder return of 23.19%. This suggests momentum has been building rather than fading. If...

Allegations around Cytokinetics (CYTK) and its handling of FDA communications on aficamten have pushed governance and disclosure risks to the forefront, giving investors a fresh lens on the company’s recent share performance. See our latest analysis for Cytokinetics. That backdrop helps explain why a 1 year total shareholder return of 33.83% and a 5 year total shareholder return of 229.69% sit alongside a quieter 1 year to date share price return of 1.26%. This suggests momentum has cooled as...

If you are wondering whether Intuitive Surgical's current share price lines up with its long term potential, you are not alone. This article will help you frame that question clearly. The stock recently closed at US$586.24, with returns of 3.5% over 7 days, 8.1% over 30 days, 4.3% year to date, 8.6% over 1 year, 126.4% over 3 years and 125.9% over 5 years. These figures give useful context for any valuation work you are considering. Recent news coverage has largely focused on Intuitive...

General Electric (GE) is back in focus after GE Aerospace reported Q3 revenue and adjusted operating income above analyst estimates, and secured a US$1.4b contract modification to supply turboshaft engines for U.S. Marine Corps CH-53K helicopters. See our latest analysis for General Electric. GE’s latest contract win and Q3 beat come after a mixed near term share price patch, with a 7.3% 30 day share price return but only a modest year to date move. At the same time, the very large five year...

In recent days, NETSTREIT has attracted renewed attention as UBS and Cantor Fitzgerald both reiterated Buy ratings, while the company’s CFO Daniel P. Donlan added to his holdings with a 1,000‑share purchase. This combination of external analyst confidence and internal insider buying has strengthened the perception that NETSTREIT’s leadership is aligned with shareholders’ interests. Next, we’ll examine how this wave of insider buying could influence NETSTREIT’s existing investment narrative...

Why ConocoPhillips Is On Investors’ Radar Today ConocoPhillips (COP) is drawing attention after recent price moves, with the stock last closing at US$97.51. Investors are weighing this against its recent returns and financial profile. Over the past week, the share price shows a 1.7% decline, following a roughly 1.2% drop in the latest session. That contrasts with a gain over the past month and past 3 months, as well as a small positive return year to date. At the same time, ConocoPhillips...

With no single headline event driving attention, Navitas Semiconductor (NVTS) is attracting investor interest based on its recent share performance and its ongoing role in power semiconductors across consumer and industrial applications. See our latest analysis for Navitas Semiconductor. Recent trading tells a mixed story for Navitas, with a 17.23% 1 month share price return and an 11.27% 7 day share price return set against a 19.89% 3 month share price decline and a very large 240.20% 1 year...

As the U.S. stock market navigates a mixed landscape with major indices showing varied performances and precious metals reaching record highs, investors are closely watching economic indicators and political developments that could influence market dynamics. In this environment, identifying undervalued stocks can be particularly appealing, as these opportunities may offer potential value when broader market conditions create uncertainty.

As the U.S. markets navigate a complex landscape marked by mixed stock index performances and unprecedented highs in gold and silver prices, investors are closely monitoring developments such as the DOJ's probe into Fed Chair Powell. Amid this backdrop, growth companies with high insider ownership can present compelling opportunities, as they often indicate strong confidence from those who know the business best.

Major stock indexes in the United States are experiencing mixed performance, with gold and silver reaching record highs amid a Justice Department probe into Federal Reserve Chair Jerome Powell. In such a fluctuating market landscape, penny stocks can present unique opportunities for investors seeking growth at lower price points. Though often associated with smaller or newer companies, these stocks can offer significant potential when backed by strong financials and sound fundamentals.

In the current market landscape, major stock indexes are showing mixed signals amid economic uncertainties and geopolitical developments, with safe-haven assets like gold reaching new highs. As investors navigate these fluctuations, small-cap stocks present unique opportunities for growth and diversification. Identifying promising small caps involves looking for companies with strong fundamentals and innovative strategies that can thrive even in a turbulent market environment.

In the current U.S. market landscape, major stock indexes are showing mixed performances amid heightened scrutiny of Federal Reserve actions and record highs in gold and silver prices. As investors navigate this complex environment, dividend stocks like Civista Bancshares offer a potential avenue for stability and income, making them an attractive consideration for those seeking to bolster their portfolios against economic uncertainties.

Easterly Government Properties stock: recent returns and income profile Easterly Government Properties (DEA) has drawn investor attention after a mixed run in its recent returns, with gains over the past month and past 3 months contrasting with weaker one year and multi year performance. See our latest analysis for Easterly Government Properties. The recent 7 day share price return of 4.34% and 30 day gain of 2.05% to around $22.36 sit against a weaker 1 year total shareholder return of...

In early January 2026, President Trump proposed lifting the 2027 U.S. defense budget to about US$1.50 trillion and signed an executive order tying defense contractors’ access to contracts and CEO pay to reinvestment in weapons production rather than dividends or stock buybacks. This policy mix of much higher planned spending and tighter capital-return constraints could reshape how General Dynamics allocates cash between growth projects and shareholder returns. We’ll now examine how the...

Planet Labs PBC recently secured a seven-year satellite contract with an Asia-Pacific partner that has helped it deliver three consecutive quarters of positive free cash flow and significantly expand its order backlog. This shift from cash burn to cash generation suggests that Planet Labs’ business model is maturing, with longer-term contracts providing greater operational visibility and financial resilience. We’ll now explore how Planet Labs’ emergence as a free cash flow generator reshapes...

SentinelOne (S) is back in focus after Piper Sandler moved to a Neutral rating, citing recent management changes, limited near term catalysts, and disappointment with recent company results despite confidence in the security platform. See our latest analysis for SentinelOne. At a share price of $15.12, SentinelOne has seen a 1 day share price return of 1.37% decline and a 90 day share price return of 11.22% decline, while the 1 year total shareholder return of 31.02% decline suggests fading...

Danaher recently announced at the J.P. Morgan Healthcare Conference that it expects fourth-quarter 2025 revenues to grow in the mid-single digit percent range year over year, with non-GAAP core revenue growth tracking toward the high end of its prior low-single digit guidance. The company also pointed to improving industry conditions, including finalized tariff rules and reduced customer inventories, as factors supporting its operational strengths and long-term value focus. We’ll now examine...

Recently, Star Bulk Carriers has been in focus as the Baltic Dry Index retreated sharply over the past month, raising concerns about pressure on near-term freight rates, earnings, and dividends ahead of the company’s fourth-quarter and full-year 2025 results release, scheduled for February 25, 2026. At the same time, analyst expectations for stronger year-over-year earnings and a top Zacks Rank highlight contrasting optimism about Star Bulk’s upcoming performance despite softer industry...

Event context and recent price performance Azenta (AZTA) has drawn investor interest after recent share price moves, with the stock closing at US$37.92 and showing double digit gains over the past 3 months, despite a weaker 1 year total return. See our latest analysis for Azenta. The recent 23.92% 3 month share price return contrasts with a 27.45% decline in 1 year total shareholder return, so momentum has picked up lately even though longer term investors remain under water. If Azenta has...